Search results
Showing 1471 to 1485 of 2184 results for guidelines
However, the recommendations on tinnitus support and management in this guideline specify that everyone should receive tinnitus support...
However, the recommendations on tinnitus support and management in this guideline specify that everyone should receive tinnitus support...
would help to guide the optimal use of these limited resources and future guideline recommendations. Source guidance details Comes from...
Social Care User Experience Survey). However, the evidence reviewed for this guideline suggests that measures of this kind may have...
Evidence-based recommendations on abemaciclib (Verzenios) for treating locally advanced or metastatic, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer in adults who have not had endocrine-based therapy before.
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab (TA629)
Evidence-based recommendations on obinutuzumab (Gazyvaro) with bendamustine for follicular lymphoma that has not responded or has progressed up to 6 months after treatment with rituximab or a rituximab-containing regimen in adults.
Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March
Evidence-based recommendations on romosozumab (EVENITY) for severe osteoporosis in people after menopause who are at high risk of fracture.
NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures .
Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 (TA971)
Evidence-based recommendations on remdesivir (Veklury) and tixagevimab plus cilgavimab (Evusheld) for treating COVID-19.
Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)
NICE has developed a medtech innovation briefing (MIB) on Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions .
NICE has developed a medtech innovation briefing (MIB) on AI technologies for detecting diabetic retinopathy .
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer (TA632)
Evidence-based recommendations on trastuzumab emtansine (Kadcyla) for human epidermal growth factor receptor 2 (HER2)-positive early breast cancer in adults who have residual invasive disease in the breast or lymph nodes after neoadjuvant taxane-based and HER2-targeted therapy.
Is obesity an independent risk factor for perinatal morbidity and mortality?
the woman's preference and obstetric indications in line with the NICE guideline on intrapartum care for health women and babies . There...
Any explanatory notes(if applicable) Why this is important:- The guideline committee felt that primary care was well suited to managing...